“Our method’s ability to produce mature human podocytes from iPS cells w/ high yield and w/o the need for subpopulation selection or genetic manipulations offers researchers and clinicians a robust, renewable source of kidney cells" - @thesamiramusah https://t.co/vS1DumLffp
Both organoids and Organs-on-Chips have potential in assessing the efficacy and safety of drugs, chemicals and cosmetics, with possible applications in regenerative medicine https://t.co/7qK1z6SIIS